MedLife supplements syndicated loan with EUR 50 mln, to EUR 268.3 mln: “Keeping a cautious approach, the new funds will be used mainly for new acquisitions”
After dozens of acquisitions and organic projects at national level, as well as unprecedented investments in medical technology, MedLife announces a period of consolidation and streamlining of activity, with an emphasis on a gradual…
- After dozens of acquisitions and organic projects at national level, as well as unprecedented investments in medical technology, MedLife announces a period of consolidation and streamlining of activity, with an emphasis on a gradual increase in margins, simultaneously with a medium-term improvement of the debt/ebitda.
- In the long term, MedLife will continue its strategy of expansion and acquisitions, the new funds accessed being a reserve in this sense.
- A Romanian company, listed on the Bucharest Stock Exchange, with a well-defined strategy, MedLife has demonstrated over time the ability to develop healthily, registering consecutive increases of over 20% in turnover over the last five years in a row.
- The systematic, non-opportunistic construction of the largest medical network in Romania brought significant advantages not only in terms of brand awareness and trust, but especially in terms of democratizing access to quality medical services at national level. MedLife is probably the most reliable private medical operator in Romania.
MedLife (BVB: M), the largest network of private medical services in Romania and the only company with Romanian capital among the top operators of private medical services listed on the Stock Exchange, announces the signing of the addendum regarding the increase of the credit limit by an additional amount of EUR 50 million, according to the approval received from shareholders during the 22 December 2023 EGSM, the total value of the borrowed capital thus reaching EUR 268.3 million.
The syndicate of banks that signed the credit limit increase consists of Banca Comercială Română, as coordinator, mandated as main arranger, documentation agent, facility and guarantee agent and financier, Raiffeisen Bank and BRD Groupe Societe Generale as main arrangers trustees and financiers and Banca Transilvania and ING Bank N.V. Amsterdam Bucharest Branch, as main arrangers and financiers.
“For almost 30 years we have been building the largest medical network in Romania, and for more than 10 years we have been a reliable partner for dozens of local entrepreneurs, MedLife proving excellent results both in terms of acquisition of new companies as well as regarding their related integration processes. There are still relevant opportunities in the market that would allow the Group to maintain the current trend of expansion and consolidation of the medical services market, while capturing additional profitability. Keeping a cautious approach, we want to evaluate these opportunities, the additional funds will be used mainly for the development of M&A processes, with a focus on acquisitions of profitable companies that will largely not affect profitability and debt indicators at Group level.
